Rita Araújo

Ms. Rita Araújo

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 November 2019 in Metabolites
Verified
Journal Article
Open access
PDF file
Tatiana João CarneiroTatiana João Carneiro
Tatiana João Carneiro
RARita Araújo
Rita Araújo
MVMartin Vojtek
Martin Vojtek
SGSalomé Gonçalves-Monteiro
Salomé Gonçalves-Monteiro
CDCarmen Diniz
Carmen Diniz
Ana GilAna Gil
Ana Gil
This work describes, to our knowledge, the first NMR metabolomics analysis of mice kidney, liver, and breast tissue in response to cisplatin exposure, in search of early metabolic signatures of cisplatin biotoxicity. Balb/c mice were exposed to a single 3.5 mg/kg dose of cisplatin and then euthanized; organs (kidney, liver, breast tissue) were collected at 1, 12, and 48 h. Polar tissue extracts were analyzed by NMR spectroscopy, and the resulting spectra were studied by multivariate and univariate analyses. The results enabled the identification of the most significant deviant metabolite levels at each time point, and for each tissue type, and showed that the largest metabolic impact occurs for kidney, as early as 1 h post-injection. Kidney tissue showed a marked depletion in several amino acids, comprised in an overall 13-metabolites signature. The highest number of changes in all tissues was noted at 12 h, although many of those recovered to control levels at 48 h, with the exception of some persistently deviant tissue-specific metabolites, thus enabling the identification of relatively longer-term effects of cDDP. This work reports, for the first time, early (1–48 h) concomitant effects of cDDP in kidney, liver, and breast tissue metabolism, thus contributing to the understanding of multi-organ cDDP biotoxicity.

Verified
Journal Article
Open access
PDF file
Tatiana João CarneiroTatiana João Carneiro
Tatiana João Carneiro
RARita Araújo
Rita Araújo
MVMartin Vojtek
Martin Vojtek
SGSalomé Gonçalves-Monteiro
Salomé Gonçalves-Monteiro
ACAna Batista de Carvalho
Ana Batista de Carvalho
Ana GilAna Gil
Ana Gil
The interest in palladium(II) compounds as potential new anticancer drugs has increased in recent years, due to their high toxicity and acquired resistance to platinum(II)-derived agents, namely cisplatin. In fact, palladium complexes with biogenic polyamines (e.g., spermine, Pd2Spm) have been known to display favorable antineoplastic properties against distinct human breast cancer cell lines. This study describes the in vivo response of triple-negative breast cancer (TNBC) tumors to the Pd2Spm complex or to cisplatin (reference drug), compared to tumors in vehicle-treated mice. Both polar and lipophilic extracts of tumors, excised from a MDA-MB-231 cell-derived xenograft mouse model, were characterized through nuclear magnetic resonance (NMR) metabolomics. Interestingly, the results show that polar and lipophilic metabolomes clearly exhibit distinct responses for each drug, with polar metabolites showing a stronger impact of the Pd(II)-complex compared to cisplatin, whereas neither drug was observed to significantly affect tumor lipophilic metabolism. Compared to cisplatin, exposure to Pd2Spm triggered a higher number of, and more marked, variations in some amino acids, nucleotides and derivatives, membrane precursors (choline and phosphoethanolamine), dimethylamine, fumarate and guanidine acetate, a signature that may be relatable to the cytotoxicity and/or mechanism of action of the palladium complex. Putative explanatory biochemical hypotheses are advanced on the role of the new Pd2Spm complex in TNBC metabolism.

27 November 2017 in Journal of Cancer Research and Clinical Oncology
Verified
Journal Article
Closed access
PDF file
RARita Araújo
Rita Araújo
Joana SantosJoana Santos
Joana Santos
MFMara Fernandes
Mara Fernandes
Francisca DiasFrancisca Dias
Francisca Dias
HSHugo Sousa
Hugo Sousa
Rui M. Gil da CostaRui M. Gil da Costa
Rui M. Gil da Costa

17 February 2021 in Metabolites
Verified
Journal Article
Open access
PDF file
Tatiana João CarneiroTatiana João Carneiro
Tatiana João Carneiro
RARita Araújo
Rita Araújo
MVMartin Vojtek
Martin Vojtek
SGSalomé Gonçalves-Monteiro
Salomé Gonçalves-Monteiro
CDCarmen Diniz
Carmen Diniz
Ana GilAna Gil
Ana Gil
Pd(II)-compounds are presently regarded as promising anticancer drugs, as an alternative to Pt(II)-based drugs (e.g., cisplatin), which typically trigger severe side-effects and acquired resistance. Dinuclear Pd(II) complexes with biogenic polyamines such as spermine (Pd2Spm) have exhibited particularly beneficial cytotoxic properties, hence unveiling the importance of understanding their impact on organism metabolism. The present study reports the first nuclear magnetic resonance (NMR)-based metabolomics study to assess the in vivo impact of Pd2Spm on the metabolism of healthy mice, to identify metabolic markers with possible relation to biotoxicity/side-effects and their dynamics. The changes in the metabolic profiles of both aqueous and lipophilic extracts of mice kidney, liver, and breast tissues were evaluated, as a function of drug-exposure time, using cisplatin as a reference drug. A putative interpretation was advanced for the metabolic deviations specifically triggered by Pd2Spm, this compound generally inducing faster metabolic response and recovery to control levels for all organs tested, compared to cisplatin (except for kidney lipid metabolism). These results constitute encouraging preliminary metabolic data suggestive of potential lower negative effects of Pd2Spm administration.

1 April 2017 in Life Sciences
Verified
Journal Article
Closed access
Joana SantosJoana Santos
Joana Santos
MFMara Fernandes
Mara Fernandes
RARita Araújo
Rita Araújo
HSHugo Sousa
Hugo Sousa
JRJoana Ribeiro
Joana Ribeiro
Rui MedeirosRui Medeiros
Rui Medeiros

Verified
Journal Article
Open access
PDF file
JRJoão A. Rodrigues
João A. Rodrigues
DBDaniela S. C. Bispo
Daniela S. C. Bispo
MSMónica G. Silva
Mónica G. Silva
RARita Araújo
Rita Araújo
ASAmadeu Soares
Amadeu Soares
Ana GilAna Gil
Ana Gil
This paper reports on an NMR metabolomics study of lipophilic extracts of Ruditapes philippinarum clams exposed to the hormonal contaminant 17-α-ethinylestradiol (EE2), at 17 °C and 21 °C. The results reveal that exposure at 17 °C triggers a weak response at low EE2 concentrations, suggestive of a slight increase in membrane rigidity, followed by lipid metabolic stability at higher EE2 concentrations. On the other hand, at 21 °C, lipid metabolism begins to respond at 125 ng/L EE2, with antioxidant docosahexaenoic acid (DHA) helping to tackle high-oxidative-stress conditions, in tandem with enhanced storage of triglycerides. Exposure to 625 ng/L EE2 (highest concentration) enhances phosphatidylcholine (PtdCho) and polyunsaturated fatty acid (PUFA) levels, their direct intercorrelation suggesting PUFA incorporation in new membrane phospholipids. This should lead to increased membrane fluidity, probably aided by a decrease in cholesterol. PUFA levels, considered a measure of membrane fluidity, were strongly (and positively) correlated to intracellular glycine levels, thus identifying glycine as the main osmolyte entering the cells under high stress. Membrane fluidity also seems to elicit the loss of taurine. This work contributes to the understanding of the mechanisms of response of R. philippinarum clams to EE2 in tandem with warming while unveiling novel potential markers of stress mitigation, namely high levels of PtdCho, PUFAs (or PtdCho/glycerophosphocholine and PtdCho/acetylcholine ratios) and linoleic acid and low PUFA/glycine ratios.